Related Experiment Video
Updated: Jun 24, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[Prognostic factors in renal cell carcinoma]
N Letang1, L Cabaniols, D Pouessel
1Service d'urologie, hôpital Lapeyronie, 371, avenue du Doyen-Gaston-Giraud, 34295 Montpellier cedex 05, France.
Bulletin Du Cancer
|April 10, 2009
Summary
Identifying prognostic factors in renal cell carcinoma (RCC) is crucial for patient care and treatment. New molecular factors may enhance current prognostic models, requiring further clinical validation.
Area of Science:
- Oncology
- Medical Research
Context:
- Accurate prognostic factor identification in renal cell carcinoma (RCC) is vital for patient counseling, treatment selection, and clinical trial enrollment.
- Current prognostic systems for RCC, including TNM classification, Fuhrmann grade, histological subtype, symptoms, and performance status, require enhancement for improved predictive accuracy.
Purpose:
- To review the importance of prognostic factors in renal cell carcinoma (RCC).
- To discuss existing prognostic systems (UISS, SSIGN, French Group, Motzer model) and the potential impact of new molecular factors.
Summary:
- Prognostic factors in RCC encompass anatomical, histological, clinical, and molecular elements.
- Existing prognostic systems for localized and metastatic RCC are effective but may be improved by incorporating novel molecular data.
- New prognostic algorithms and nomograms are being developed to enhance predictive accuracy.
Impact:
- Improved patient information and tailored treatment strategies for renal cell carcinoma.
- Enhanced selection of patients for clinical trials and adapted treatment schedules.
- Potential for future prognostic systems to integrate molecular factors, necessitating validation in large prospective trials.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...